January 15, 2025

Research

Salus’ Research on Using Deep Learning to Detect Smart Contract Vulnerability Published in Scientific Reports, a sub-journal of Nature

Daniel Levi November 29, 2023

Q-Learning: Advancing Towards AGI and Artificial Superintelligence (ASI) through Reinforcement Learning

Daniel Levi November 23, 2023

China launches the world’s fastest internet with 1.2 terabit per second link, can transmit 150 4K movies per second

Daniel Levi November 15, 2023

25 Best SaaS Alternatives & Competitors

Daniel Levi September 12, 2023

This dual solar-powered reactor converts plastic waste and CO2 ‘from thin air’ into sustainable fuels

Nickie Louise June 19, 2023

Top 10 Technologies and Ideas From Science Fiction That Became Reality

Daniel Levi June 8, 2023

Biotech startup Sensydia secures $3M in NIH funding grant to revolutionize heart disease screening

Nickie Louise June 5, 2023

Scientists reverse diabetes in mice by hacking human cells to make insulin

Daniel Levi June 5, 2023

Chinese electric car startup JAC unveils the world’s first EV car that runs on SODIUM-ion battery

Daniel Levi May 30, 2023

FDA approves Neuralink’s first-in-human clinical trial of brain-implant

Nickie Louise May 26, 2023

Google Cloud launches two new AI-powered tools to accelerate drug discovery and precision medicine

Daniel Levi May 16, 2023

‘Purdue Innovates’ launches one united IP commercialization and startup creation network

Nickie Louise April 20, 2023

Global crypto adoption remains high, reaching 425 million in 2022 despite the industry crisis fueled by FTX collapse: Report

Daniel Levi January 19, 2023

Crypto industry is riding out the bear market, DappRadar’s new Q3 industry report shows

Daniel Levi October 7, 2022

Quantum communications startup Qunnect lands $8M led by Airbus Ventures to usher in the era of quantum internet

Nickie Louise October 5, 2022

Traces of mRNA vaccine found in the breast milk of lactating women, a new JAMA Pediatrics study found

Daniel Levi September 26, 2022

Pfizer CEO explains the decision to go with mRNA: “mRNA was a technology that never delivered a single product until that day… It was most counterintuitive to go the mRNA route,” Albert Bourla says

Daniel Levi September 6, 2022

2

Newer Posts Older Posts

© Copyright TechStartups.com 2024